Our Blog

août 22, 2017

Allurion’s Shantanu Gaur on Jim Cramer’s Mad Money

Allurion Technologies founder discusses his company’s non-invasive ‘balloon’ pill that helps treat obesity from CNBC.

juin 8, 2017

Why Stomach Balloons are the Future of Healthcare

The rise of the balloon field is not only revolutionizing obesity but also emblematic of shifts occurring in healthcare systems all around the world. Dr. Shantanu Gaur explores these themes in his latest post on MedCityNews. Click here for the full post.

avril 3, 2017

Allurion Repays Massachusetts Life Sciences Center

5 years ago, the Massachusetts Life Sciences Center​ awarded us an Accelerator Loan that made the R&D and clinical testing possible for us to secure private investment. The loan program has helped countless companies grow and expand in Massachusetts. Today, we announce repayment of that loan! Thank you to the Center, Senator Karen Spilka​, and Governor Charlie Baker​ for your support. We will continue to make Massachusetts proud!

mars 6, 2017

Elipse Balloon Multi-Center Study Published

We are pleased to announce the publication of our European multi-center trial results in Endoscopy! Thank you to our European investigators and patients who participated in a groundbreaking study on the Elipse Balloon.

mars 5, 2017

Obesity is Complex. Why Aren’t its Treatments?

In a recent article on MedCityNews, Dr. Shantanu Gaur and Michael Fergusson (CEO of Ayogo) explore the next generation of more personalized obesity treatments. Click here for the article.

janvier 23, 2017

Allurion Named Finalist in Lyfebulb-Novo Nordisk Innovation Summit

We were honored to be finalists at the Lyfebulb – Novo Nordisk Innovation Summit. Here is a video of our founder, Dr. Shantanu Gaur, presenting the Elipse Balloon to a packed crowd!

mai 6, 2016

Allurion Technologies’ Elipse Intragastric Balloon Receives Prestigious SAGES Innovation Award

Allurion Technologies announced today that its flagship product, the Elipse Balloon, has received the prestigious Emerging Technology Innovation Award from the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Allurion Co-Founder and Chief Scientific Officer Dr. Shantanu Gaur The Elipse Device is the world’s first procedureless™ intragastric balloon: it is placed and removed without surgery, endoscopy or anesthesia. It is the first intragastric balloon to receive this award. The Elipse System received European Union CE marking in late 2015 and is now available at leading weight loss centers in the United Kingdom, Italy and France. Plans for commercial expansion within Europe…

avril 14, 2016

Why have healthcare companies and physicians failed to solve the obesity epidemic?

In a recent guest post on MedCity News, Dr. Shantanu Gaur asks why healthcare companies and physicians have failed to solve the obesity epidemic. The answer has much more to do with how we treat the consumer than how we think about technology. Check out the article here!

février 23, 2016

Three Things The Tech Industry Has Right And The Medical Industry Has Wrong

Dr. Shantanu Gaur recently authored a guest post on TechCrunch on what the medtech industry can learn from the tech industry. Namely, 1) be open with data; 2) create an experience, not just a product; and 3) treat users as participants, not just purchasers. Check out the article here!

décembre 8, 2015

Elipse System Receives European Marketing Approval

Today, we are happy to announce that the Elipse System has received European marketing approval! The Elipse Balloon is now available for sale in select centers in Europe. Please read the press release for more details.